APOE and atherosclerosis: For example, wefound that treatment with the dual PPARα/γ agonist, compound 3q, was associated with amarked increase in atherosclerosis in control apoE KO mice [104] (see Figure 5), while PPARγ and α agonistsused alone in this model were protective [8, 9].